RN7SL202P

Across TCGA pan-cancer cohorts, RN7SL202P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RN7SL202P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RN7SL202P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL202P expression acts as an unfavorable survival marker, although some lineages such as LUSC and PAAD show a favorable association.

UCS, THCA, and COAD are the cancer types where RN7SL202P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	III,IV	0.266	0.622	.008	72	view →
THCA	OS	Tertile	II,III,IV	0.540	0.894	.001	60	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	42	view →
UCEC	OS	Tertile	IV	0.066	0.755	<.001	36	view →
LUSC	OS	Tertile	II,III,IV	0.901	0.606	.010	36	view →
PAAD	DFS	Tertile	II,III,IV	0.554	0.221	.016	30	view →
SKCM	DFS	Tertile	IV	0.040	0.620	.003	30	view →
KIRP	OS	Tertile	All	1.000	0.919	.024	30	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	27	view →
ACC	OS	Tertile	II,III,IV	0.135	0.658	.010	27	view →
LGG	OS	Tertile	All	0.564	0.402	.001	23	view →
KIRC	DFS	Tertile	II,III,IV	0.489	0.683	.021	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RN7SL202P–UCS (OS)

Open the UCS breakdown →